Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction
Top Cited Papers
- 1 March 2001
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 141 (3), 367-374
- https://doi.org/10.1067/mhj.2001.113215
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunctionProgress in Cardiovascular Diseases, 1999
- Natriuretic peptides in assessment of left-ventricular dysfunctionScandinavian Journal of Clinical and Laboratory Investigation, 1999
- Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban populationThe Lancet, 1997
- Brain natriuretic peptide predicts mortality in the elderly.Heart, 1997
- Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failureThe American Journal of Cardiology, 1995
- Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.JCI Insight, 1995
- Clinical utility of transthoracic two-dimensional and Doppler echocardiographyJournal of the American College of Cardiology, 1994
- Plasma brain natriuretic peptide in assessment of acute dyspnoeaThe Lancet, 1994
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureThe New England Journal of Medicine, 1984
- Left ventricular volume from paired biplane two-dimensional echocardiography.Circulation, 1979